Merck KGaA's MilliporeSigma teams with Simtra in ADC manufacturing partnership
While the race is on to develop antibody-drug conjugate cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma and Simtra BioPharma Solutions, who have forged a five-year partnership.
